Department of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
Department of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
Ann Thorac Surg. 2021 Dec;112(6):1841-1846. doi: 10.1016/j.athoracsur.2020.12.009. Epub 2020 Dec 19.
Resection of lung cancer infiltrating the aortic arch or the subclavian artery can be accomplished in selected patients with the use of cardiopulmonary bypass (CPB). Direct cross-clamping of the aortic arch and the left subclavian artery without CPB for radical resection of the tumor can be an alternative. This study presents one group's experience with this technique.
Between October 2016 and May 2019, 9 patients (5 male, 4 female) underwent radical resection of lung cancer infiltrating the aortic arch (n = 5) or the left subclavian artery (n = 4) by direct cross-clamping technique at Sapienza University of Rome, Italy. Seven left upper lobectomies, 1 left pneumonectomy, and 1 left upper sleeve lobectomy were performed. Reconstruction of the aortic arch was performed by direct suturing or polyethylene terephthalate (Dacron) patch, whereas the subclavian artery was reconstructed with a Dacron conduit. Three patients received neoadjuvant chemotherapy.
Patients' mean age was 64.7 ± 13.3 years (range, 36 to 78 years). Aortic arch resection was partial in all cases (adventitial in 1 and full thickness in 4); left subclavian artery resection was adventitial in 2 patients and circumferential in 2. All the resections were complete. Prosthetic reconstruction was performed in 4 cases. Mean operative time was 130 ± 25.6 minutes; mean vascular clamping time was 28.2 ± 3.2 minutes. No mortality occurred. The major complication rate was 11.1 %. At a mean follow-up of 17 ± 9 months (range, 5 to 29 months), the recurrence rate was 33.3%. Median survival was 20 months.
Direct cross-clamping as an alternative to CPB for resection of lung cancer infiltrating the aortic arch or the subclavian artery is a feasible, safe, and reliable procedure in selected patients.
在选择性患者中,使用体外循环(CPB)可完成肺癌浸润主动脉弓或锁骨下动脉的切除术。不使用 CPB 直接夹闭主动脉弓和左锁骨下动脉,对肿瘤进行根治性切除术,这是一种替代方法。本研究介绍了一组应用该技术的经验。
2016 年 10 月至 2019 年 5 月,意大利罗马 Sapienza 大学的 9 例患者(5 例男性,4 例女性)接受了直接夹闭技术治疗肺癌浸润主动脉弓(n=5)或左锁骨下动脉(n=4)的根治性切除术。行 7 例左上肺叶切除术、1 例左全肺切除术和 1 例左上肺袖状切除术。主动脉弓重建采用直接缝合或聚对苯二甲酸乙二醇酯(涤纶)补片,锁骨下动脉重建采用涤纶导管。3 例患者接受了新辅助化疗。
患者的平均年龄为 64.7±13.3 岁(范围 36 岁至 78 岁)。所有病例均行主动脉弓部分切除术(1 例外膜切除术,4 例全层切除术);左锁骨下动脉切除术,2 例外膜切除术,2 例环状切除术。所有的切除均为完全性。4 例患者行假体重建。平均手术时间为 130±25.6 分钟;平均血管阻断时间为 28.2±3.2 分钟。无死亡病例发生。主要并发症发生率为 11.1%。平均随访 17±9 个月(5 个月至 29 个月),复发率为 33.3%。中位生存时间为 20 个月。
在选择性患者中,不使用 CPB 直接夹闭作为肺癌浸润主动脉弓或锁骨下动脉切除术的替代方法,是一种可行、安全和可靠的方法。